N/A
N=33
HPV DNA Testing Through Mobile Mammography Unit
Cervical Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03551028 ↗Enrolled (actual)
33
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Acceptability of Self-Collection Paired With Mobile Mammography — 33 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- HPV self collection (Device)
- Age
- Adult, Older Adult · 30+ yrs
- Sex
- Female
- Sponsor
- University of Virginia
- Primary completion
- Mar 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability of Self-Collection Paired With Mobile Mammography |
33 | — |
| PRIMARY Feasibility of Self-Collection for HPV Paired With Mobile Mammography |
33 | — |
Summary
Invasive cervical cancer incidence and mortality can be dramatically reduced through early detection and treatment, but many women do not complete screening at recommended intervals. Many low-income women in Virginia remain uninsured and are at significant risk of being medically underserved and failing to complete regular cervical cancer screening. Self-collection of specimens for HPV testing is an innovative approach that may increase access to cervical cancer screening in populations that do not participate in traditional clinic-based screening. Innovative delivery models are needed to reach at-risk populations. This study seeks to explore the acceptability and feasibility of pairing self-collection of HPV samples for DNA testing with mobile mammography in women living in rural Virginia.
Eligibility Criteria
Inclusion Criteria
- not pregnant
Exclusion Criteria
- history of hysterectomy or pelvic RT non English speaking
Data sourced from ClinicalTrials.gov (NCT03551028). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.